Sharps Technology Inc. Warrant (STSSW)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Sharps Technology Inc. Warrant Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BO Brian Oliveira Clear Street Group Inc. | 539,074 | $26,954.02 | $16,172.22 | -$10,781.8 | -40% |
Sharps Technology Inc. Warrant (STSSW) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Sharps Technology Inc. Warrant ever had a stock split?
Sharps Technology Inc. Warrant Profile
| Capital Markets Industry | Financials Sector | Paul Kruger Danner CEO | NASDAQ (CM) Exchange | 82003F119 CUSIP |
| US Country | 55 Employees | - Last Dividend | 2 Dec 2022 Last Split | 14 Apr 2022 IPO Date |
Overview
Sharps Technology, Inc. is a forefront medical device company based in Melville, New York, that engages in the research, design, development, manufacture, distribution, and sale of innovative safety syringe products within the United States. Established in 2017, the company aims to revolutionize the administration of vaccines and injectable medications through its cutting-edge syringe technologies, prioritizing user safety and minimizing waste. With its dedicated pursuit of excellence in the medical device industry, Sharps Technology, Inc. continues to strive towards improving healthcare practices and patient outcomes with its advanced solutions.
Products and Services
- Sharps Provensa
An innovative ultra-low waste space syringe developed by Sharps Technology, Inc., Sharps Provensa is designed to significantly reduce medication waste while ensuring safe and precise administration of vaccines and various injectable medications. This product exemplifies the company's commitment to environmental sustainability and healthcare safety, offering a technologically advanced solution for healthcare providers and patients alike.
